What is Definium Therapeutics, Inc. Common Shares's Market Cap?

Definium Therapeutics, Inc. Common Shares's Market Cap is $5.1B, based on as-reported figures from SEC (XBRL) filings.

What is Definium Therapeutics, Inc. Common Shares's Enterprise Value?

Definium Therapeutics, Inc. Common Shares's Enterprise Value is $4.1B, based on as-reported figures from SEC (XBRL) filings.

What is Definium Therapeutics, Inc. Common Shares's EV / EBITDA?

Definium Therapeutics, Inc. Common Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Definium Therapeutics, Inc. Common Shares's Net Income (TTM)?

Definium Therapeutics, Inc. Common Shares's Net Income (TTM) is -$353.8M, based on as-reported figures from SEC (XBRL) filings.

What is Definium Therapeutics, Inc. Common Shares's EBITDA?

Definium Therapeutics, Inc. Common Shares's EBITDA is -$227.5M, based on as-reported figures from SEC (XBRL) filings.

What is Definium Therapeutics, Inc. Common Shares's Diluted EPS (TTM)?

Definium Therapeutics, Inc. Common Shares's Diluted EPS (TTM) is -2.63, based on as-reported figures from SEC (XBRL) filings.

What is Definium Therapeutics, Inc. Common Shares's Net Debt?

Definium Therapeutics, Inc. Common Shares's Net Debt is -$1.0B, based on as-reported figures from SEC (XBRL) filings.

Definium Therapeutics, Inc. Common Shares (DFTX) Financial Statements

Definium Therapeutics, Inc. Common Shares

SIC 2833 · MEDICINAL CHEMICALS & BOTANICAL PRODUCTS

FIGI BBG001TCSL84

XNAS · usd

38.23▲ 0.14 (0.37%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close38.09

Day's Range37.70 – 39.26

52-Week Range14.62 – 49.70

Volume1.4M

Avg Volume2.0M

Share Statistics

Shares Outstanding

Employees106

ExchangeXNAS

Listed2020-03-03

Share count as of July 30, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Definium Therapeutics, Inc. Common Shares (DFTX)

What is Definium Therapeutics, Inc. Common Shares's Market Cap?: Definium Therapeutics, Inc. Common Shares's Market Cap is $5.1B, based on as-reported figures from SEC (XBRL) filings.
What is Definium Therapeutics, Inc. Common Shares's Enterprise Value?: Definium Therapeutics, Inc. Common Shares's Enterprise Value is $4.1B, based on as-reported figures from SEC (XBRL) filings.
What is Definium Therapeutics, Inc. Common Shares's EV / EBITDA?: Definium Therapeutics, Inc. Common Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Definium Therapeutics, Inc. Common Shares's Net Income (TTM)?: Definium Therapeutics, Inc. Common Shares's Net Income (TTM) is -$353.8M, based on as-reported figures from SEC (XBRL) filings.
What is Definium Therapeutics, Inc. Common Shares's EBITDA?: Definium Therapeutics, Inc. Common Shares's EBITDA is -$227.5M, based on as-reported figures from SEC (XBRL) filings.
What is Definium Therapeutics, Inc. Common Shares's Diluted EPS (TTM)?: Definium Therapeutics, Inc. Common Shares's Diluted EPS (TTM) is -2.63, based on as-reported figures from SEC (XBRL) filings.
What is Definium Therapeutics, Inc. Common Shares's Net Debt?: Definium Therapeutics, Inc. Common Shares's Net Debt is -$1.0B, based on as-reported figures from SEC (XBRL) filings.